The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Month: October 2019

ORNL scientists shed light on microbial ‘dark matter’ with new approach
Pharma & Human Health

ORNL scientists shed light on microbial ‘dark matter’ with new approach

OCT 8, 2019
BASF and Biomillenia join forces in microbiome research to promote healthy skin
Finance

BASF and Biomillenia join forces in microbiome research to promote healthy skin

OCT 8, 2019
4D Pharma collaborates with MSD to develop Live Biotherapeutics for vaccines
Finance

4D Pharma collaborates with MSD to develop Live Biotherapeutics for vaccines

OCT 8, 2019
Researchers unlock potential to use CRISPR to alter the microbiome
GMO & Synbio

Researchers unlock potential to use CRISPR to alter the microbiome

OCT 8, 2019
Bacteria can be used to heal aspirin-induced ulcers: Irish research reveals
Pharma & Human Health

Bacteria can be used to heal aspirin-induced ulcers: Irish research reveals

OCT 7, 2019
Biomica Advances to Pre-Clinical Studies in its IBD Program
Gastrointestinal

Biomica Advances to Pre-Clinical Studies in its IBD Program

OCT 4, 2019
Evolve BioSystems Jointly Files Patent Infringement Complaint Against Abbott Laboratories
Biotics and Supplements

Evolve BioSystems Jointly Files Patent Infringement Complaint Against Abbott Laboratories

OCT 1, 2019